arcoxia 30 mg tablets
organon pharma israel ltd., israel - etoricoxib - film coated tablets - etoricoxib 30 mg - etoricoxib - etoricoxib - arcoxia tablets are indicated for the symptomatic relief of osteoarthritis (oa).
atorvastatin basics 30 mg film-coated tablets
basics gmbh hemmelrather weg 201 51377 leverkusen, germany - atorvastatin calcium, trihydrate - film-coated tablet - atorvastatin calcium trihydrate 30 mg - lipid modifying agents
codeine phosphate 30mg tablets bp
aurobindo pharma limited - codeine phosphate - tablets - 30mg - mild to moderate pain dry or painful cough diarrhoea
aripiprazole teva 30mg tablets
teva uk limited - aripiprazole - tablets - 30mg - nervous system; psycholeptics; antipsychotics; other antipsychotics - it is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
aripiprazole milpharm 30mg tablets
milpharm limited - aripiprazole - tablets - 30mg - other antipsychotic - it is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older.
targin oxycodone hydrochloride / naloxone hydrochloride anhydrous 60/30 mg modified release tablets blister pack
mundipharma pty ltd - oxycodone hydrochloride, quantity: 60 mg; naloxone hydrochloride dihydrate, quantity: 32.7 mg (equivalent: naloxone hydrochloride?, qty 30 mg) - tablet, modified release - excipient ingredients: ethylcellulose; stearyl alcohol; lactose monohydrate; purified talc; magnesium stearate; povidone; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - targin modified release tablet is indicated for the management of severe pain where:,- other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and,- the pain is opioid-responsive; and,- requires daily, continuous, long term treatment.,targin modified release tablet is not indicated for use in chronic non-cancer pain other than in exceptional circumstances.,targin modified release tablet is not indicated as an as-needed (prn) analgesia,the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.,targin is indicated as a second line symptomatic treatment of patients with severe to very severe idiopathic restless legs syndrome after failure of dopaminergic therapy.
otezla apremilast 30 mg film coated tablet blister pack
amgen australia pty ltd - apremilast, quantity: 30 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; ferrosoferric oxide - otezla is indicated for: ? the treatment of signs and symptoms of active psoriatic arthritis in adult patients. ? the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy. ? the treatment of adult patients with oral ulcers associated with beh?et?s disease who are candidates for systemic therapy.
abyraz aripiprazole 30 mg tablet blister pack
alphapharm pty ltd - aripiprazole, quantity: 30 mg - tablet, uncoated - excipient ingredients: hyprolose; microcrystalline cellulose; sodium starch glycollate type a; purified water; lactose monohydrate; magnesium stearate; iron oxide red - abyraz is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.
mirtazapine sandoz mirtazapine 30mg tablets bottle
sandoz pty ltd - mirtazapine, quantity: 30 mg - tablet, film coated - excipient ingredients: macrogol 8000; magnesium stearate; hypromellose; iron oxide red; titanium dioxide; colloidal anhydrous silica; iron oxide yellow; iron oxide black; hyprolose; maize starch; lactose monohydrate - treatment of major depression.
mirtazapine 30mg tablets
dowelhurst ltd - mirtazapine - oral tablet - 30mg